POU2AF1

protein-coding

POU class 2 homeobox associating factor 1

Gene summary

Enables transcription coactivator activity. Involved in positive regulation of transcription by RNA polymerase II. Part of RNA polymerase II transcription regulator complex. [provided by Alliance of Genome Resources, Jul 2025]

MANE transcript

NM_006235.3

Inheritance

AR

ClinVar variants

U:26B:7

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.18

Max pathogenic AF

—

Genomic locus

chr11:111,352,255-111,455,630

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~103.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

agammaglobulinemiaMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0015977

Submitter: PanelApp Australia

agammaglobulinemiaLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0015977

Submitter: ClinGen

*POU2AF1*, encoding the Bob1 protein, was first reported in relation to autosomal recessive agammaglobulinemia in 2021 by Kury et al (PMID: 33571536). This is the only report of a patient with a Bob1 deficiency caused by a homozygous *POU2AF1* null mutation (NM_006235.3:c.233del) resulting in a severe B-cell–intrinsic defect. B-cell receptor signaling was reduced and plasmablast development and immunoglobulin secretion seemed abrogated in the patient. This gene-disease relationship is supported by experimental evidence; the highly B lymphocyte-specific pattern of *POU2AF1* expression in lymphocytes, together with its selective stimulatory effect on immunoglobulin promoters strongly indicates that *POU2AF1*is a critical determinant of immunoglobulin transcription in lymphoid cells (PMID: 7859290), which is deficient in patient cells but can be rescued by lentiviral reconstitution (PMID: 33571536). The immunologic manifestations in the patient showed some overlap with the Bob1 knockout mice (PMIDs: 8977324, 8849727, 8849728, 35603192). Patient T cells were normal in terms of distribution and activation except for a reduction in circulating T-follicular helper (TFH) cells (PMID: 33571536). While it has been shown that *POU2AF1* does not act as a transcriptional coactivator for T cells (PMID: 35285071) the observed defect in T follicular helper differentiation is likely related to its functional impact in B cells, however, in a mouse model, it was shown that *POU2AF1* is expressed in activated (not naïve) T cells, and when deleted in T cells had a positive regulatory impact on autoimmune diabetes, suggesting that it has a role to play in T-cell-driven autoimmunity, and facilitates polarization of activated T helper cells to a TH17 phenotype (PMID: 33295943). In summary, there is limited evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Antibody Deficiencies GCEP on 09/20/2022 (SOP Version 9). Of note, in B cells, CD19 and *POU2AF1* may also serve as diagnostic and prognostic biomarkers of chronic obstructive pulmonary disease (PMID: 35479834). Additionally, expression of *POU2AF1* in non-lymphocytes, specifically in airway epithelium appears to contribute to regulation of host immunity (PMID: 26927796).

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to POU2AF1 variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 32
not providedTotal: 7

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_006235.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
1
clinvar
5
missense
23
clinvar
2
clinvar
25
nonsense
0
start loss
0
frameshift
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total00266133
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 8 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_006235.3RefSeqNP_006226.25MANE Select
ENST00000393067.8EnsemblENSP00000376786.35MANE Select
ENST00000531398.1EnsemblENSP00000433527.14Standard
XM_005271593.3RefSeqXP_005271650.15Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • transcription by RNA polymerase II
  • humoral immune response
  • positive regulation of transcription by RNA polymerase II

Molecular Function

  • RNA polymerase II proximal promoter sequence-specific DNA binding
  • RNA polymerase II core promoter sequence-specific DNA binding
  • transcription coregulator activity
  • transcription coactivator activity
  • protein binding

Cellular Component

  • RNA polymerase II transcription factor complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000393067
Coding exons
5
Length
103379
Individuals with no LoFs
125691
Homozygous LoFs
0
Heterozygous LoFs
4
Defined
125695
p
0.0000159
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.9491201530.7840.000008981595
Missense (PolyPhen)3255.3180.57847628
Synonymous-1.148471.71.170.00000480564
Loss of Function2.53211.10.1805.45e-7119

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian0.0000540.000054rare
Finnish00.0absent
European (Non-Finnish)0.0000260.000026rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers.;
Disease
DISEASE: Note=A chromosomal aberration involving POU2AF1/OBF1 may be a cause of a form of B-cell leukemia. Translocation t(3;11)(q27;q23) with BCL6. {ECO:0000269|PubMed:8574789}.;

Recessive Scores

pRec
0.276

Intolerance Scores

LoFtool
0.0796
RVIS EVS
-0.32
RVIS percentile EVS
31.69

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.263

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.